JP2023538608A5 - - Google Patents
Info
- Publication number
- JP2023538608A5 JP2023538608A5 JP2023512162A JP2023512162A JP2023538608A5 JP 2023538608 A5 JP2023538608 A5 JP 2023538608A5 JP 2023512162 A JP2023512162 A JP 2023512162A JP 2023512162 A JP2023512162 A JP 2023512162A JP 2023538608 A5 JP2023538608 A5 JP 2023538608A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- pyrrolo
- pyridine
- dimethyl
- methylsulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063067465P | 2020-08-19 | 2020-08-19 | |
| US63/067,465 | 2020-08-19 | ||
| PCT/US2021/046434 WO2022040267A1 (en) | 2020-08-19 | 2021-08-18 | 1h-pyrrolo[3,2-c]pyridine and 1h-pyrrolo[2,3-c]pyridine derivatives as tlr9 inhibitors for the treatment of fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538608A JP2023538608A (ja) | 2023-09-08 |
| JP2023538608A5 true JP2023538608A5 (enExample) | 2024-08-26 |
Family
ID=77711459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512162A Pending JP2023538608A (ja) | 2020-08-19 | 2021-08-18 | 線維症の処置のためのｔｌｒ９阻害剤阻害剤としての１ｈ－ピロロ［３，２－ｃ］ピリジンおよび１ｈ－ピロロ［２，３－ｃ］ピリジン誘導体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12590091B2 (enExample) |
| EP (1) | EP4200298B1 (enExample) |
| JP (1) | JP2023538608A (enExample) |
| KR (1) | KR20230053646A (enExample) |
| CN (1) | CN115867549A (enExample) |
| AR (1) | AR123285A1 (enExample) |
| AU (1) | AU2021328577A1 (enExample) |
| BR (1) | BR112023002646A2 (enExample) |
| CA (1) | CA3189826A1 (enExample) |
| ES (1) | ES3034264T3 (enExample) |
| IL (1) | IL300643A (enExample) |
| MX (1) | MX2023001929A (enExample) |
| TW (1) | TW202214233A (enExample) |
| WO (1) | WO2022040267A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11807622B2 (en) | 2019-01-30 | 2023-11-07 | Insilico Medicine Ip Limited | TLR 9 inhibitors |
| EP4479135A1 (en) * | 2022-02-18 | 2024-12-25 | Bristol-Myers Squibb Company | Substituted imidazopyridinyl compounds useful as inhibitors of tlr9 |
| KR20250109202A (ko) * | 2022-11-10 | 2025-07-16 | 브리스톨-마이어스 스큅 컴퍼니 | Tlr9의 억제제로서 유용한 치환된 벤즈이미다졸 화합물 |
| CN120152957A (zh) * | 2022-11-10 | 2025-06-13 | 百时美施贵宝公司 | 用作tlr9抑制剂的经取代的喹诺酮 |
| WO2024163380A1 (en) * | 2023-01-31 | 2024-08-08 | Bristol-Myers Squibb Company | Substituted benzimidazole compounds useful as inhibitors of tlr9 |
| TW202504599A (zh) | 2023-06-30 | 2025-02-01 | 美商必治妥美雅史谷比公司 | Kras抑制劑 |
| WO2026039512A1 (en) | 2024-08-14 | 2026-02-19 | Bristol-Myers Squibb Company | Kras inhibitors |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060235037A1 (en) | 2005-04-15 | 2006-10-19 | Purandare Ashok V | Heterocyclic inhibitors of protein arginine methyl transferases |
| GB0602178D0 (en) | 2006-02-03 | 2006-03-15 | Merck Sharp & Dohme | Therapeutic treatment |
| JP2009532501A (ja) | 2006-04-04 | 2009-09-10 | ミリアド ジェネティクス， インコーポレイテッド | 疾患および障害のための化合物 |
| US8785489B2 (en) | 2008-10-17 | 2014-07-22 | Boehringer Ingelheim International Gmbh | Heteroaryl substituted indole compounds useful as MMP-13 inhibitors |
| US20130158066A1 (en) | 2011-12-20 | 2013-06-20 | Hoffmann-La Roche Inc. | 4-azaindole inhibitors of crac |
| US20130158049A1 (en) | 2011-12-20 | 2013-06-20 | Hoffmann-La Roche Inc. | 7-azaindole inhibitors of crac |
| WO2013156431A1 (en) | 2012-04-17 | 2013-10-24 | Syngenta Participations Ag | Pesticidally active pyridyl- and pyrimidyl- substituted thiazole and thiadiazole derivatives |
| EP2738172A1 (en) | 2012-11-28 | 2014-06-04 | Almirall, S.A. | New bicyclic compounds as crac channel modulators |
| CA2933466A1 (en) * | 2013-12-13 | 2015-06-18 | Takeda Pharmaceutical Company Limited | Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors |
| AR107032A1 (es) | 2015-12-09 | 2018-03-14 | Padlock Therapeutics Inc | Inhibidores bicíclicos de pad4 |
| US10071079B2 (en) | 2016-06-29 | 2018-09-11 | Bristol-Myers Squibb Company | [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds |
| MX391344B (es) | 2016-07-30 | 2025-03-21 | Bristol Myers Squibb Co | Compuestos indol sustituidos con dimetoxifenilo como inhibidores de receptores tipo toll 7, 8 o 9 (tlr7, tlr8 o tlr9). |
| JP7028861B2 (ja) | 2016-09-09 | 2022-03-02 | ブリストル－マイヤーズ スクイブ カンパニー | ピリジル置換のインドール化合物 |
| EP3538513A1 (en) | 2016-11-11 | 2019-09-18 | Dynavax Technologies Corporation | Toll-like receptor antagonist compounds and methods of use |
| US11399542B2 (en) | 2017-07-05 | 2022-08-02 | Syngenta Participations Ag | Pesticidally active heterocyclic derivatives with sulfur containing substituents |
| ES2921020T3 (es) | 2017-08-04 | 2022-08-16 | Bristol Myers Squibb Co | Compuestos de indol sustituidos con [1,2,4]triazolo[4,3-a]piridinilo |
| CN110997656B (zh) | 2017-08-04 | 2023-04-14 | 百时美施贵宝公司 | 用作tlr7/8/9抑制剂的取代的吲哚化合物 |
| WO2019099336A1 (en) | 2017-11-14 | 2019-05-23 | Bristol-Myers Squibb Company | Substituted indole compounds |
| AU2018386201A1 (en) | 2017-12-15 | 2020-07-30 | Bristol-Myers Squibb Company | Substituted indole ether compounds |
| JP7289301B2 (ja) | 2017-12-18 | 2023-06-09 | ブリストル－マイヤーズ スクイブ カンパニー | ４－アザインドール化合物 |
| SG11202005704RA (en) * | 2017-12-19 | 2020-07-29 | Bristol Myers Squibb Co | 6-azaindole compounds |
| US11878975B2 (en) | 2017-12-19 | 2024-01-23 | Bristol-Myers Squibb Company | Substituted indole compounds useful as TLR inhibitors |
| CN111511730B (zh) | 2017-12-19 | 2023-07-25 | 百时美施贵宝公司 | 可用作tlr抑制剂的被酰胺取代的吲哚化合物 |
| CA3085937A1 (en) | 2017-12-20 | 2019-06-27 | Bristol-Myers Squibb Company | Diazaindole compounds |
| KR102730859B1 (ko) | 2017-12-20 | 2024-11-15 | 브리스톨-마이어스 스큅 컴퍼니 | 아릴 및 헤테로아릴 치환된 인돌 화합물 |
| SG11202005694RA (en) | 2017-12-20 | 2020-07-29 | Bristol Myers Squibb Co | Amino indole compounds useful as tlr inhibitors |
| AU2019319835A1 (en) | 2018-08-08 | 2021-03-25 | Bristol-Myers Squibb Company | Indole and azaindole inhibitors of PAD enzymes |
-
2021
- 2021-08-18 AU AU2021328577A patent/AU2021328577A1/en not_active Abandoned
- 2021-08-18 US US18/042,069 patent/US12590091B2/en active Active
- 2021-08-18 IL IL300643A patent/IL300643A/en unknown
- 2021-08-18 TW TW110130428A patent/TW202214233A/zh unknown
- 2021-08-18 ES ES21769261T patent/ES3034264T3/es active Active
- 2021-08-18 AR ARP210102329A patent/AR123285A1/es not_active Application Discontinuation
- 2021-08-18 MX MX2023001929A patent/MX2023001929A/es unknown
- 2021-08-18 JP JP2023512162A patent/JP2023538608A/ja active Pending
- 2021-08-18 WO PCT/US2021/046434 patent/WO2022040267A1/en not_active Ceased
- 2021-08-18 CN CN202180050340.3A patent/CN115867549A/zh active Pending
- 2021-08-18 KR KR1020237009022A patent/KR20230053646A/ko active Pending
- 2021-08-18 BR BR112023002646A patent/BR112023002646A2/pt not_active Application Discontinuation
- 2021-08-18 CA CA3189826A patent/CA3189826A1/en active Pending
- 2021-08-18 EP EP21769261.5A patent/EP4200298B1/en active Active